Biote Corp. - Class A common stock (BTMD)

Frequently Asked Questions About Biote Corp. - Class A common stock (BTMD)

Are there any risks associated with hormone replacement therapy?

Like any medical treatment, hormone replacement therapy carries potential risks and side effects. Common concerns may include weight changes, mood fluctuations, and, in some cases, increased risk factors for certain medical conditions. Biote emphasizes the importance of making informed decisions and conducting thorough evaluations before starting treatment. Patients are encouraged to discuss their individual risks and benefits with their healthcare provider.

How can patients access Biote's services?

Patients interested in accessing Biote's services can typically do so by consulting with a healthcare provider trained in hormone optimization therapy. Biote maintains a network of affiliated medical clinics and practitioners who are equipped to provide personalized hormone replacement therapy based on individual needs. Patients can locate providers through Biote's website or by contacting the company directly for assistance.

How does Biote ensure the quality of its products?

Biote ensures the quality of its products by adhering to rigorous manufacturing practices compliant with the FDA and other regulatory standards. The company collaborates with accredited compounding pharmacies that follow Good Manufacturing Practices (GMP) to produce hormone pellets and other therapies. Additionally, Biote conducts extensive research and clinical studies to validate the safety and effectiveness of its offerings.

How does Biote support healthcare providers?

Biote supports healthcare providers through extensive training programs, workshops, and resources focused on hormone optimization therapies. The company offers in-depth courses to educate practitioners about bioidentical hormone replacement therapy (BHRT), ensuring they have the knowledge and tools necessary to effectively implement treatment plans. Additionally, Biote provides ongoing support and marketing assistance to help clinics successfully integrate hormone therapy into their services.

How has the COVID-19 pandemic affected Biote Corp.?

The COVID-19 pandemic posed several challenges for Biote Corp., as it affected healthcare operations, patient access, and routine medical consultations. However, the company adapted by utilizing telehealth solutions and remote patient engagement strategies to maintain continuity of care. Biote's resilient approach to navigating the pandemic underscored its commitment to supporting both healthcare providers and patients during difficult times.

Is Biote Corp. involved in clinical research?

Yes, Biote Corp. is actively involved in clinical research to advance the understanding of hormone optimization therapy. The company conducts studies to evaluate the efficacy and safety of its products and seeks to contribute to the scientific literature on bioidentical hormone replacement therapy (BHRT). This research component helps Biote enhance its treatment protocols and validate the benefits of hormone optimization.

What are the potential benefits of hormone replacement therapy?

Hormone replacement therapy can provide numerous benefits, including relief from symptoms associated with hormonal imbalance, such as fatigue, mood swings, weight gain, and low libido. Patients undergoing hormone optimization therapy may experience improved energy levels, enhanced mood, better sleep quality, and an overall improved quality of life. Biote's specialized approach aims to tailor treatment to individual patient needs for optimal results.

What are the primary products offered by Biote?

Biote offers a range of products for hormone replacement therapy, primarily focusing on bioidentical hormone pellets. These pellets are designed for both men and women to help balance hormone levels effectively. Additionally, Biote provides educational materials and training programs for healthcare practitioners to facilitate the appropriate use of their products.

What are the qualifications of Biote's medical advisory board?

Biote's medical advisory board consists of highly qualified healthcare professionals with expertise in hormone therapy, endocrinology, and related fields. Members are selected based on their extensive clinical experience, contributions to research, and commitment to advancing patient care in hormonal optimization. This board plays a pivotal role in guiding the company's strategies and ensuring that Biote remains at the forefront of medical best practices.

What does Biote Corp. do?

Biote Corp. is a leading healthcare company focused on hormone optimization therapy, particularly bioidentical hormone replacement therapy (BHRT) using various delivery methods. The company aims to enhance the quality of life for its patients by addressing hormonal balance through customized treatment plans. With an emphasis on education and training for healthcare providers, Biote seeks to increase awareness and accessibility of hormone optimization for both men and women.

What financial performance metrics are important for Biote investors?

Investors in Biote Corp. should pay attention to several financial performance metrics, including revenue growth, profitability margins, and cash flow. Key indicators such as earnings per share (EPS), operating income, and overall market share in the hormone replacement therapy sector are also significant. Monitoring these metrics can provide insights into the company's operational efficiency and long-term growth potential.

What is Biote's commitment to patient education?

Biote is deeply committed to patient education, believing that informed patients are better equipped to make decisions regarding their health. The company provides a wealth of resources, including informative articles, webinars, and support materials, to educate individuals about hormone optimization and the potential benefits of therapy. This focus on education empowers patients to engage actively in their treatment journey.

What is hormone optimization therapy?

Hormone optimization therapy involves the supplementation of hormones through various methods to achieve a balance that may improve health and well-being. This therapy is used to address conditions related to hormonal imbalance, such as fatigue, mood swings, weight gain, and decreased libido. Biote specializes in bioidentical hormone replacement therapy (BHRT) to provide a more natural alternative to synthetic hormones.

What is the mission of Biote Corp.?

The mission of Biote Corp. is to empower individuals to take control of their health by providing effective hormone optimization therapies and education for healthcare providers. The company aims to enhance the well-being of patients by promoting awareness of hormonal health and making bioidentical hormone replacement therapy accessible to those in need.

What sets Biote apart from its competitors?

Biote distinguishes itself from competitors through its comprehensive focus on education and training for healthcare professionals. The company's commitment to developing a robust network of trained practitioners ensures that patients receive high-quality and personalized care. Biote's emphasis on bioidentical hormone therapy, along with a patient-centric approach, further solidifies its position in the hormone optimization market.

When did Biote Corp. go public?

Biote Corp. went public in October 2021. The company completed its initial public offering (IPO), trading under the ticker symbol 'BTMD' on the Nasdaq Stock Market. This milestone allowed Biote to access additional capital to further its mission of promoting hormone optimization therapy.

Where can I find more information about Biote Corp.?

More information about Biote Corp. can be obtained through its official website, which offers comprehensive details about its products, services, company history, and mission. Additionally, investor relations sections provide updates on financial performance, press releases, and upcoming events. Social media platforms and online educational resources are also excellent avenues for staying informed about Biote's latest developments.

Where is Biote Corp. located?

Biote Corp. is headquartered in Irving, Texas. The location serves as a central hub for the company's operations, research, and development as well as training for healthcare practitioners across the United States. This strategic location positions Biote to effectively coordinate its nationwide network and provide support to its clinical partners.

Who are Biote Corp.'s primary customers?

Biote Corp.'s primary customers include healthcare providers, such as physicians and medical clinics, who administer hormone replacement therapies to patients seeking to restore hormonal balance. Additionally, the end customers are individuals experiencing symptoms of hormonal imbalance, including men and women of various age groups looking for solutions to improve their quality of life.

What is the current price of Biote Corp. - Class A common stock?

The current price of Biote Corp. - Class A common stock is 2.940

When was Biote Corp. - Class A common stock last traded?

The last trade of Biote Corp. - Class A common stock was at 4:00 pm EDT on October 23rd, 2025

What is the market capitalization of Biote Corp. - Class A common stock?

The market capitalization of Biote Corp. - Class A common stock is 171.17M

How many shares of Biote Corp. - Class A common stock are outstanding?

Biote Corp. - Class A common stock has 58.22M shares outstanding.